- Home
- BOLD vs WAI Comparison
BOLD vs WAI Comparison
Compare BOLD & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- WAI
- Stock Information
- Founded
- BOLD 2018
- WAI 2018
- Country
- BOLD United States
- WAI China
- Employees
- BOLD N/A
- WAI N/A
- Industry
- BOLD
- WAI
- Sector
- BOLD
- WAI
- Exchange
- BOLD Nasdaq
- WAI NYSE
- Market Cap
- BOLD 30.3M
- WAI 33.5M
- IPO Year
- BOLD 2024
- WAI 2023
- Fundamental
- Price
- BOLD $1.18
- WAI $0.47
- Analyst Decision
- BOLD Buy
- WAI
- Analyst Count
- BOLD 3
- WAI 0
- Target Price
- BOLD $4.00
- WAI N/A
- AVG Volume (30 Days)
- BOLD 353.5K
- WAI 1.8M
- Earning Date
- BOLD 08-11-2025
- WAI 08-24-2025
- Dividend Yield
- BOLD N/A
- WAI N/A
- EPS Growth
- BOLD N/A
- WAI N/A
- EPS
- BOLD N/A
- WAI N/A
- Revenue
- BOLD N/A
- WAI $3,750,352.00
- Revenue This Year
- BOLD N/A
- WAI N/A
- Revenue Next Year
- BOLD N/A
- WAI N/A
- P/E Ratio
- BOLD N/A
- WAI N/A
- Revenue Growth
- BOLD N/A
- WAI N/A
- 52 Week Low
- BOLD $1.00
- WAI $0.46
- 52 Week High
- BOLD $4.72
- WAI $20.00
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- WAI N/A
- Support Level
- BOLD N/A
- WAI N/A
- Resistance Level
- BOLD N/A
- WAI N/A
- Average True Range (ATR)
- BOLD 0.00
- WAI 0.00
- MACD
- BOLD 0.00
- WAI 0.00
- Stochastic Oscillator
- BOLD 0.00
- WAI 0.00
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).